文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Hospitalization for patients in the United States (US) and European Union (EU) treated with inotuzumab ozogamicin (InO) vs standard of care (SOC) for relapsed/refractory acute lymphoblastic leukemia (R/R ALL) in a global phase 3 trial.
复制论文ID
分享
摘要
作者
参考文献
暂无分享,去
创建一个
V. Welch
|
E. Vandendries
|
F. Loberiza
|
Yunchao Su
|
I. V. Oostrum
保存到论文桶